The complete European guidelines on phenylketonuria: diagnosis and treatment
2017 · Orphanet Journal of Rare Diseases · 806 citations
https://doi.org/10.1186/s13023-017-0685-2
K
Kirsten Ahring
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
2.7K
Citations
25
h-index
36
i10-index
Kirsten Ahring is an academic researcher from Copenhagen University Hospital. The author has contributed to research in topics: Metabolism and Genetic Disorders & Diet and metabolism studies & Mitochondrial Function and Pathology. The author has an h-index of 25, co-authored 56 publications.
ORCID: 0000-0002-6518-2226Papers by this author
worksCan untreated PKU patients escape from intellectual disability? A systematic review
2018 · Orphanet Journal of Rare Diseases · 60 citations
https://doi.org/10.1186/s13023-018-0890-7
Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria
2019 · Molecular Genetics and Metabolism · 32 citations
https://doi.org/10.1016/j.ymgme.2019.07.018
Behavioural effects of phenylalanine‐free amino acid tablet supplementation in intellectually disabled adults with untreated phenylketonuria
2005 · Acta Paediatrica · 30 citations
https://doi.org/10.1111/j.1651-2227.2005.tb02078.x
Early feeding practices in infants with phenylketonuria across Europe
2018 · Molecular Genetics and Metabolism Reports · 30 citations
https://doi.org/10.1016/j.ymgmr.2018.07.008
European guidelines on diagnosis and treatment of phenylketonuria: First revision
2025 · Molecular Genetics and Metabolism · 28 citations
https://doi.org/10.1016/j.ymgme.2025.109125
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat